I agree that this site is using cookies. You can find further informations here.
X
Uyl-de Groot, Carin A.
550  results:
Search for persons X
?
1

New systemic treatment paradigms in resectable non-small ce..:

Houda, Ilias ; Dickhoff, Chris ; Uyl-de Groot, Carin A....
The Lancet Regional Health - Europe.  38 (2024)  - p. 100840 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Assessing the clinical benefit of systemic anti-cancer trea..:

Leeneman, Brenda ; Xander, Nicolas S.H. ; Fiets, W. Edward...
European Journal of Cancer.  202 (2024)  - p. 114002 , 2024
Link: https://doi.org/10.1016/..
 
?
3

The Role of Medical Societies and the Relevance of Clinical..:

Julian, Elaine ; Solà-Morales, Oriol ; Garcia, Maria João...
Journal of Market Access & Health Policy.  12 (2024)  3 - p. 128-143 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Challenges and controversies in resectable non-small cell l..:

Houda, Ilias ; Dickhoff, Chris ; Uyl-de Groot, Carin A....
The Lancet Regional Health - Europe.  38 (2024)  - p. 100841 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Non-contrast short MRI surveillance for HCC screening: the ..:

van de Braak, Céline ; Willemssen, François E. J. A. ; de Man, Rob A....
European Radiology Experimental.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

Unraveling elements of value-based pricing from a pharmaceu..:

Dane, Aniek ; Uyl-de Groot, Carin ; van der Kuy, Hugo
Frontiers in Pharmacology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
7

Market entry agreements for innovative pharmaceuticals subj..:

Heine, Renaud J.S.D. ; Mathijssen, Ron H.J. ; Verbeek, Floor A.J...
Value in Health.  , 2024
Link: https://doi.org/10.1016/..
 
?
8

A health technology assessment of personalized nutrition in..:

Galekop, Milanne Maria Johanna ; del Bas, Josep Maria ; Calder, Philip C...
International Journal of Technology Assessment in Health Care.  40 (2024)  1 - p. , 2024
Link: https://doi.org/10.1017/..
 
?
9

Broadening the HTA of medical AI: A review of the literatur..:

Boverhof, Bart-Jan ; Redekop, W. Ken ; Visser, Jacob J...
Health Policy and Technology.  13 (2024)  2 - p. 100868 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Economic Evaluation of a Personalized Nutrition Plan Based ..:

Galekop, Milanne Maria Johanna ; Uyl-de Groot, Carin ; Redekop, William Ken
PharmacoEconomics - Open.  8 (2023)  2 - p. 313-331 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Attribution of value for combination immune checkpoint inhi..:

Zaim, Remziye ; Redekop, Ken ; Uyl-de Groot, Carin A.
Journal of Cancer Policy.  35 (2023)  - p. 100382 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Changes in survival in de novo metastatic cancer in an era ..:

Luyendijk, Marianne ; Visser, Otto ; Blommestein, Hedwig M...
JNCI: Journal of the National Cancer Institute.  115 (2023)  6 - p. 628-635 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Cost-effectiveness and budget impact of pembrolizumab+axiti..:

Xander, Nicolas S. H. ; Fiets, W. Edward ; Uyl-de Groot, Carin A.
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
14

P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PA..:

Pennings, Elise R.A. ; Durmaz, Müjde ; Visser, Otto...
HemaSphere.  7 (2023)  S3 - p. e992046d , 2023
Link: https://doi.org/10.1097/..
 
?
15

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly d..:

Chamuleau, Martine E D ; Stenner, Frank ; Chitu, Dana A...
The Lancet Haematology.  10 (2023)  12 - p. e966-e975 , 2023
Link: https://doi.org/10.1016/..
 
1-15